Definition and concept of Controlled and novel Drug delivery systems with available examples, viz. parenteral, transdermal, buccal, rectal, nasal, implants, ocular

Curriculum Unit: 7. Controlled and Novel Drug Delivery Systems:

This study module covers "Definition and concept of Controlled and novel Drug delivery systems with available examples, viz. parenteral, transdermal, buccal, rectal, nasal, implants, ocular", an integral component of the Year 3 Doctor of Pharmacy (Pharm.D) curriculum under Pharmaceutical Formulations (Controlled and Novel Drug Delivery Systems). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.

Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:

• Master the physical, chemical, and biological principles underlying Definition and concept of Controlled and novel Drug delivery systems with available examples, viz. parenteral, transdermal, buccal, rectal, nasal, implants, ocular.
• Examine formulation design, drug release kinetics, and bioavailability determinants.
• Apply standard industrial and clinical quality control guidelines to Controlled and Novel Drug Delivery Systems.
• Explore drug delivery optimization and stability protocols in pharmacy practice.

Standard literature and institutional sources for Pharmaceutical Formulations:

• [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
• [2]Applied Biopharmaceutics & Pharmacokinetics (Leon Shargel & Andrew B.C. Yu)
• [3]Remington: The Science and Practice of Pharmacy (Allen et al.)
• [4]Aulton's Pharmaceutics: The Design and Manufacture of Medicines (Taylor & Aulton)